We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current CUBT market cap is 10.76M. The company's latest EPS is USD -0.0106 and P/E is -1.89.
| Year End 31 December 2022 | 2022 |
|---|---|
| USD (US$) | |
| Total Revenue | 0 |
| Operating Income | -4.44M |
| Net Income | -5.69M |
| Year End 31 December 2022 | 2022 |
|---|---|
| USD (US$) | |
| Total Assets | 2.09M |
| Total Liabilities | 4.49M |
| Total Equity | -20.53M |
| Year End 31 December 2022 | 2022 |
|---|---|
| USD (US$) | |
| Operating | -1.54M |
| Investing | -77k |
| Financing | 1M |
| Market Cap | 10.76M |
| Price to Earnings Ratio | -1.89 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 200 |
| Price to Book Ratio | -4.49 |
| Dividend Yield | - |
| Shares Outstanding | 537.88M |
| Average Volume (1 week) | 107.26k |
| Average Volume (1 Month) | 157.66k |
| 52 Week Change | 6.38% |
| 52 Week High | 0.04 |
| 52 Week Low | 0.0051 |
| Spread (Intraday) | 0 (17%) |
| Company Name | Curative Biotechnology Inc (PK) |
| Address |
1825 nw corporate blvd., #110 boca raton, florida 33431 |
| Website | https://curativebiotech.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
